User profiles for Colin R Simpson
 | Colin R SimpsonVictoria University of Wellington Verified email at vuw.ac.nz Cited by 11555 |
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events
have led to some countries restricting its use. Using a national prospective cohort, we …
have led to some countries restricting its use. Using a national prospective cohort, we …
[HTML][HTML] Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
Background The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca)
COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical …
COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical …
SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …
Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people
Background— We examined whether population-level hospitalization rates for heart failure (HF)
and subsequent survival have continued to improve since the turn of the century. We …
and subsequent survival have continued to improve since the turn of the century. We …
[HTML][HTML] Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million …
Background Current UK vaccination policy is to offer future COVID-19 booster doses to
individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of …
individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of …
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in …
Background Reports suggest that COVID-19 vaccine effectiveness is decreasing, but whether
this reflects waning or new SARS-CoV-2 variants—especially delta (B.1.617.2)—is unclear…
this reflects waning or new SARS-CoV-2 variants—especially delta (B.1.617.2)—is unclear…
Trends in the epidemiology of asthma in England: a national study of 333,294 patients
CR Simpson, A Sheikh - Journal of the Royal Society of …, 2010 - journals.sagepub.com
Background Observations in the UK at the end of the last century found increasing trends of
asthma prevalence over time. However, it has been reported that the number of new cases …
asthma prevalence over time. However, it has been reported that the number of new cases …
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2· 57 million people in Scotland (EAVE II): a prospective cohort …
…, FDR Hobbs, M Woolhouse, CR Simpson… - The Lancet …, 2021 - thelancet.com
Background The UK COVID-19 vaccination programme has prioritised vaccination of those
at the highest risk of COVID-19 mortality and hospitalisation. The programme was rolled out …
at the highest risk of COVID-19 mortality and hospitalisation. The programme was rolled out …
The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases
Background There are a lack of reliable data on the epidemiology and associated burden
and costs of asthma. We sought to provide the first UK-wide estimates of the epidemiology, …
and costs of asthma. We sought to provide the first UK-wide estimates of the epidemiology, …
A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland
… Colin R Simpson2, … Murphy NF, Simpson CR, McAlister FA, et al. National survey of the
prevalence, incidence, primary care burden, and treatment of heart failure in Scotland. Heart2004;…
prevalence, incidence, primary care burden, and treatment of heart failure in Scotland. Heart2004;…
